Copyright
©The Author(s) 2015.
World J Hepatol. Nov 28, 2015; 7(27): 2757-2764
Published online Nov 28, 2015. doi: 10.4254/wjh.v7.i27.2757
Published online Nov 28, 2015. doi: 10.4254/wjh.v7.i27.2757
Table 4 Factors associated with hepatocellular carcinoma development (n = 231)
| Risk factor | Univariate analysis | Multivariate analysis | OR | 95%CI |
| P-value | P-value | |||
| Age (over 60 yr) | 0.012 | Not significant | ||
| HCC treatment history | < 0.001 | < 0.001 | 15.27 | 4.98-59.51 |
| AFP levels at 24 wk after IFN treatment ≥ 10 ng/mL | 0.003 | 0.009 | 3.89 | 1.38-11.94 |
| DCP levels at 24 wk after IFN treatment ≥ 40 mAU/mL | < 0.001 | < 0.001 | 24.43 | 4.11-238.67 |
- Citation: Shakado S, Sakisaka S, Chayama K, Okanoue T, Toyoda J, Izumi N, Matsumoto A, Takehara T, Ido A, Hiasa Y, Yoshioka K, Nomura H, Ueno Y, Seike M, Kumada H. Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development. World J Hepatol 2015; 7(27): 2757-2764
- URL: https://www.wjgnet.com/1948-5182/full/v7/i27/2757.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i27.2757